Advertisement
Screener

Cardio Diagnostics Holdings, Inc. (CDIO) Graph

CDIO Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2021-06-30: Income tax $0.00; Net income -$397.00.

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

CDIO revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Reportable Segments$5.36KRevenue$5.36KOperating expenses$1.50MOperating income-$1.50MOther income, net-$3.32KResearch & development$162.93KPre-tax income-$1.50MNet income-$1.50M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 1 month

Period endIncome taxNet income
2021-06-30$0.00-$397.00

Revenue and expense 3 month

Period endRevenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$5.36K$162.93K(m)$1.50M(m)-$1.50M
2026-03-31$2.68K$129.78K(m)$1.79M(m)-$1.79M
2025-12-31$3.56K*$286.87K*(m)$1.47M*(m)-$1.47M*
2025-09-30$2.85K$189.05K$1.71M$1.71M(m)-$1.71M
2025-06-30$7.47K$178.54K$1.69M$1.69M(m)-$1.68M
2025-03-31$940.00$118.78K(m)$1.63M(m)-$1.64M
2024-09-30$6.58K$5.25K$1.42M$1.42M(m)-$1.41M
2024-06-30$7.87K$7.28K$1.29M$1.29M(m)-$1.29M
2024-03-31$15.93K$10.84K(m)$4.17M(m)-$4.16M
2023-09-30$10.03K$38.71K(m)$1.45M$0.00-$1.93M
2023-06-30$1.73K$12.32K(m)$2.55M$0.00-$4.02M
2023-03-31$0.00$86.67K(m)$1.70M$0.00-$1.03M
2022-09-30$0.00$3.19K(m)$1.15M$0.00-$1.15M
2022-06-30$0.00$5.04K(m)$786.96K$0.00-$842.00K
2022-03-31$0.00$1.13K(m)$232.56K$0.00-$290.06K

Revenue and expense 4 month

Period endIncome taxNet income
2021-09-30$0.00-$721.00

Revenue and expense 6 month

Period endRevenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$8.04K$292.70K(m)$3.29M(m)-$3.29M
2025-06-30$8.41K$297.32K$3.32M$3.32M(m)-$3.32M
2024-06-30$23.80K$18.12K$5.46M$5.46M(m)-$5.45M
2023-06-30$1.73K$98.98K(m)$4.26M$0.00-$5.06M
2022-06-30$0.00$6.17K(m)$1.02M$0.00-$1.13M

Revenue and expense 7 month

Period endNet income
2021-12-31-$144.84K

Revenue and expense 9 month

Period endRevenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$11.27K$354.35K$5.03M$5.03M(m)-$5.03M
2024-09-30$30.38K$23.37K$6.88M$6.88M(m)-$6.86M
2023-09-30$11.76K$137.69K(m)$5.71M$0.00-$6.99M
2022-09-30$0.00$9.36K(m)$2.17M$0.00-$2.28M

Revenue and expense 12 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$14.82K$641.21K$6.50M(m)-$6.50M
2024-12-31$34.89K$227.97K$8.40M(m)-$8.38M
2023-12-31$17.07K$145.18K$7.26M(m)-$8.38M
2022-12-31$950.00$40.45K$4.55M$0.00-$4.66M
2021-12-31$901.00$31.47K$621.35K$0.00-$620.45K

Similar stocks

Stock NameCountryMarket CapPE Ratio
VOLITIONRX LTD (VNRX)$0.003B-0.64
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
BIOMERICA INC (BMRA)United States$0.011B
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92